{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:47:56Z","timestamp":1793886476808,"version":"4.8.0"},"reference-count":62,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"223","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2014,2,12]]},"abstract":"<jats:p>Neutralizing CXCL10 reverses established vitiligo.<\/jats:p>","DOI":"10.1126\/scitranslmed.3007811","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T14:20:27Z","timestamp":1392214827000},"source":"Crossref","is-referenced-by-count":477,"title":["CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo"],"prefix":"10.1126","volume":"6","author":[{"given":"Mehdi","family":"Rashighi","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian M.","family":"Richmond","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tajie H.","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Dresser","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Massachusetts Medical School, Worcester, MA 01605, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Wan","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia V5Z 4E8, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia V5Z 4E8, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Massachusetts Medical School, Worcester, MA 01605, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Hunter","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Luster","sequence":"additional","affiliation":[{"name":"Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Harris","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","first-page":"160","article-title":"Clinical practice. Vitiligo.","volume":"360","author":"Ta\u00efeb A.","year":"2009","unstructured":"Ta\u00efeb A., Picardo M., Clinical practice. Vitiligo. N. Engl. J. Med. 360, 160\u2013169 (2009).","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.328"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2012.1884"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12103"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2011.00878.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.181"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2011.00916.x"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005127"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.11.061"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20090603"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2007.00666_1.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.321"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.32"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.6.1203"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780138"},{"key":"e_1_3_2_17_2","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.","volume":"148","author":"Le Poole I. C.","year":"1996","unstructured":"Le Poole I. C., van den Wijngaard R. M., Westerhof W., Das P. K., Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am. J. Pathol. 148, 1219\u20131228 (1996).","journal-title":"Am. J. Pathol."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.10.043"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11197.x"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-012-0009-3"},{"key":"e_1_3_2_21_2","first-page":"534","article-title":"Treatment of generalized vitiligo with anti-TNF-\u03b1 agents.","volume":"11","author":"Alghamdi K. M.","year":"2012","unstructured":"Alghamdi K. M., Khurrum H., Taieb A., Ezzedine K., Treatment of generalized vitiligo with anti-TNF-\u03b1 agents. J. Drugs Dermatol. 11, 534\u2013539 (2012).","journal-title":"J. Drugs Dermatol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2011.10068"},{"key":"e_1_3_2_23_2","first-page":"159","article-title":"Failure of alefacept in the treatment of vitiligo.","volume":"12","author":"Bin Dayel S.","year":"2013","unstructured":"Bin Dayel S., AlGhamdi K., Failure of alefacept in the treatment of vitiligo. J. Drugs Dermatol. 12, 159\u2013161 (2013).","journal-title":"J. Drugs Dermatol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1989.01670220059008"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0923-1811(94)90057-4"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.12.031"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.463"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2006.26.462"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2010.158"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(96)80034-5"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1062"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2011.04.022"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.10.1565"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902778"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.08.016"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-095954"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.08.015"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.11.012"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.LAB.0000069521.42488.1B"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029161"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.96"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200700365"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000178263.34099.89"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007111179"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801544105"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.2.1098"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature11098"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011983"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.4.2573"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00023"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.079392"},{"key":"e_1_3_2_52_2","article-title":"Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: A phase II randomised study.","author":"Mayer L.","year":"2013","unstructured":"Mayer L., Sandborn W. J., Stepanov Y., Geboes K., Hardi R., Yellin M., Tao X., Xu L. A., Salter-Cid L., Gujrathi S., Aranda R., Luo A. Y., Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: A phase II randomised study. Gut 10.1136\/gutjnl-2012-303424 (2013).","journal-title":"Gut"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-13-2"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22957"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2007.08.011"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2568"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018907"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2013.2023"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2013.05.005"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.07.018"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/ilar.43.4.207"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2008.09.014"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/30.1.207"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.3007811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T11:59:39Z","timestamp":1705406379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.3007811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,12]]},"references-count":62,"journal-issue":{"issue":"223","published-print":{"date-parts":[[2014,2,12]]}},"alternative-id":["10.1126\/scitranslmed.3007811"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.3007811","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718276019.793522593","asserted-by":"object"}]},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,12]]}}}